News

ASCO 2026: Daraxonrasib doubles median overall survival in metastatic pancreatic cancer

ASCO 2026: Addition of immunotherapy continues to show survival benefit in prolonged follow-up in primary advanced stage or recurrent endometrial cancer

ASCO 2026: Targeted drug outperforms chemotherapy for patients with hard-to-treat lung cancer

Lifestyle can protect childhood cancer survivors

ASCO 2026: Some breast cancer patients with sentinel lymph node spread can safely skip axillary lymph node dissection

ASCO 2026: Galleri early detection test may shift timing of cancer detection, reducing stage IV diagnoses

ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma

ASCO 2026: Combining targeted immunotherapies with standard R-CHOP delays progression of aggressive B-cell lymphomas

ASCO 2026: Implanted tile-based radiation outperforms stereotactic radiotherapy for treatment of brain metastases

FDA approves durvalumab in combination with BCG for high-risk non-muscle invasive bladder cancer

Researchers develop a new sensor that could enable earlier detection of bladder cancer

Multidrug treatment using nanofibers shows promise for glioblastoma